市場調查報告書
商品編碼
1597098
歐洲色素沉著過度障礙治療市場預測至 2030 年 - 區域分析 - 按治療類型、病情和最終用戶Europe Hyperpigmentation Disorder Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type, Condition, and End User |
2022年歐洲色素沉著過度障礙治療市場價值為110099萬美元,預計2030年將達到191195萬美元;預計2022年至2030年複合年成長率為7.1%。
越來越多的色素沉著過度疾病意識計畫推動了歐洲色素沉著過度疾病治療市場
提高人們對紫外線引起的皮膚色素沉著過度認知的運動對於教育廣大民眾預防、篩檢、診斷和治療這些疾病至關重要;他們也討論了使用優質防曬產品來控制這些疾病的重要性。
2022 年 5 月 25 日,貝拉·奧羅拉 (Bella Aurora) 慶祝了國際皮膚色素沉著日。貝拉·奧羅拉(Bella Aurora)在皮膚色素沉著研究方面擁有130 多年的經驗,在西班牙和義大利著名皮膚科醫生、藥劑師和關鍵意見領袖的支持下,發起了一項國際宣傳活動來慶祝這一天。 2021 年 6 月,Dermalogica Clear 發起了一項活動,鼓勵皮膚接受並教育受眾有關發炎後色素沉著、痤瘡、痘痘等問題。
人們對黃褐斑和其他色素沉著過度疾病的認知不斷提高,導致對創新有效的治療產品和程序的需求激增。此外,它還為社會理解和管理色素沉著的方式帶來了重大而積極的變化。因此,越來越多的意識計劃促進了色素沉著過度疾病治療市場的成長。
歐洲色素沉著過度疾病治療市場概述
歐洲色素沉著過度障礙治療市場分為德國、英國、法國、義大利、西班牙和歐洲其他國家。 2023 年,德國佔據歐洲最大的色素沉著過度障礙治療市場佔有率。德國人越來越積極地尋求先進的護膚解決方案,以解決黃褐斑、老年斑和發炎後色素沉著等色素沉著過度疾病,從而推動了市場對創新療法的需求。此外,德國人口老化的加劇導致了許多與年齡相關的皮膚問題,包括色素沉著過度,促使人們尋求專門的治療來保持皮膚容光煥發。據德國聯邦統計局(Statistisches Bundesamt)稱,到2030年代中期,67歲及以上的人口數量將從400萬增加到至少2000萬。德國重視皮膚護理和抗衰老解決方案的文化,加上人口老化和皮膚病高發生率,增加了對色素沉著過度疾病治療的需求。此外,人們對外表的日益關注和擔憂仍然是增加各種整容手術需求的關鍵因素,從而促進了市場的強勁成長。此外,德國擁有先進的醫療基礎設施、熟練的皮膚科醫生和信譽良好的美容診所,有助於獲得廣泛的色素沉著過度治療和手術,吸引了尋求優質皮膚護理服務的國內外患者。
歐洲色素沉著過度疾病治療市場收入及 2030 年預測(百萬美元)
歐洲色素沉著過度疾病治療市場細分
歐洲色素沉著過度障礙治療市場按治療類型、病情、最終用戶和國家分類。
根據治療類型,歐洲色素沉著過度障礙治療市場分為藥妝、光或雷射療法、微晶煥膚、化學換膚、冷凍療法等。 2022年,藥妝領域佔據最大的市場佔有率。
根據病情,歐洲色素沉著過度障礙治療市場分為黃褐斑、日光性雀斑、發炎後色素沉著等。黃褐斑細分市場在 2022 年佔據最大的市場。
根據最終用戶,歐洲色素沉著過度障礙治療市場分為醫院、皮膚科中心等。 2022 年,醫院細分市場佔據最大的市場佔有率。
依國家/地區分類,歐洲色素沉著過度障礙治療市場分為德國、英國、法國、義大利、西班牙和歐洲其他國家。 2022 年,德國在歐洲色素沉著過度障礙治療市場佔有率中佔據主導地位。
艾伯維公司、拜耳公司、EpiPharm AG、Galderma SA、歐萊雅 SA、Lutronic Co Ltd、Obagi Cosmeceuticals LLC 和 Pierre Fabre SA 是歐洲色素沉著過度障礙治療市場的一些領先公司。
The Europe hyperpigmentation disorder treatment market was valued at US$ 1,100.99 million in 2022 and is expected to reach US$ 1,911.95 million by 2030; it is estimated to register a CAGR of 7.1% from 2022 to 2030.
Increasing Number of Hyperpigmentation Disorder Awareness Programs Drives Europe Hyperpigmentation Disorder Treatment Market
Campaigns to raise awareness about UV-induced skin hyperpigmentation are essential to educate the general populace on the prevention, screening, diagnosis, and treatment of these conditions; they also discuss the importance of using good-quality sunscreen products to manage these disorders.
On May 25, 2022, Bella Aurora celebrated the International Skin Pigmentation Day. With over 130 years of experience in the research of skin pigmentation, Bella Aurora launched an international awareness campaign to celebrate the day with the support of renowned dermatologists, pharmacists, and key opinion leaders across the Spain and Italy. In June 2021, Dermalogica Clear launched a campaign to encourage skin acceptance and educate audiences on post-inflammatory hyperpigmentation, acne, breakouts, and more.
The increased awareness of melasma and other hyperpigmentation disorders has led to a surge in demand for innovative and efficacious treatment products and procedures. Moreover, it has brought about a significant and positive change in how society understands and manages hyperpigmentation. Thus, the increasing number of awareness programs bolsters the growth of the hyperpigmentation disorder treatment market.
Europe Hyperpigmentation Disorder Treatment Market Overview
The hyperpigmentation disorder treatment market in Europe is segmented into Germany, UK, France, Italy, Spain, and Rest of Europe. The Germany held the largest Europe hyperpigmentation disorder treatment market share in 2023. Factors such as increasing awareness and emphasis on skincare and dermatological health among the population driving the market growth. Germans are increasingly proactive in seeking advanced skincare solutions to address hyperpigmentation disorders such as melasma, age spots, and post-inflammatory hyperpigmentation, driving the demand for innovative treatments in the market. Additionally, the rise in the aging population in Germany has led to numerous age-related skin concerns, including hyperpigmentation, prompting individuals to seek specialized treatments to maintain radiant skin. According to the Federal Statistical Office of Germany (Statistisches Bundesamt), the number of people aged 67 and above would increase from 4 million to at least 20 million by the mid-2030s. A culture that values skin care and anti-aging solutions, coupled with population aging and high skin disease prevalence, contributes to the demand for hyperpigmentation disorder treatments in Germany. Furthermore, rising attention and concerns about appearance continue to be a key factor in increasing the demand for various cosmetic procedures, contributing to strong market growth. Moreover, the presence of advanced medical infrastructure, skilled dermatologists, and reputable cosmetic clinics in Germany contributes to the accessibility of a wide range of hyperpigmentation treatments and procedures, attracting both domestic and international patients seeking quality skin care services.
Europe Hyperpigmentation Disorder Treatment Market Revenue and Forecast to 2030 (US$ Million)
Europe Hyperpigmentation Disorder Treatment Market Segmentation
The Europe hyperpigmentation disorder treatment market is categorized into treatment type, condition, end user, and country.
Based on treatment type, the Europe hyperpigmentation disorder treatment market is segmented into cosmeceutical, light or laser therapy, microdermabrasion, chemical peels, cryotherapy, and others. The cosmeceutical segment held the largest market share in 2022.
Based on condition, the Europe hyperpigmentation disorder treatment market is segmented into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others. The melasma segment held the largest market share in 2022.
Based on end user, the Europe hyperpigmentation disorder treatment market is segmented into hospitals, dermatology centers, and others. The hospitals segment held the largest market share in 2022.
By country, the Europe hyperpigmentation disorder treatment market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe hyperpigmentation disorder treatment market share in 2022.
AbbVie Inc, Bayer AG, EpiPharm AG, Galderma SA, L'OREAL S.A., Lutronic Co Ltd, Obagi Cosmeceuticals LLC, and Pierre Fabre SA are some of the leading companies operating in the Europe hyperpigmentation disorder treatment market.